Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Jazz Pharmaceuticals Plans $1 Bln Notes Offering, Concurrent $225 Mln Share Buyback

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ), a biopharmaceutical company, on Wednesday announced plans to offer $1 billion of exchangeable senior notes due 2032 in a private offering.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

More from Wednesday 26 August →